Form 8-K - Current report:
SEC Accession No. 0001193125-25-043338
Filing Date
2025-03-03
Accepted
2025-03-03 06:15:38
Documents
19
Period of Report
2025-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d864577d8k.htm   iXBRL 8-K 49115
2 EX-10.1 d864577dex101.htm EX-10.1 301275
3 EX-10.2 d864577dex102.htm EX-10.2 66247
4 EX-10.3 d864577dex103.htm EX-10.3 86949
5 EX-10.4 d864577dex104.htm EX-10.4 25359
6 EX-10.5 d864577dex105.htm EX-10.5 241130
  Complete submission text file 0001193125-25-043338.txt   1100042

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250228.xsd EX-101.SCH 4469
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250228_def.xml EX-101.DEF 13887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250228_lab.xml EX-101.LAB 23243
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250228_pre.xml EX-101.PRE 14856
22 EXTRACTED XBRL INSTANCE DOCUMENT d864577d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25693605
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)